Recommendations Issued for HSCT in Multiple Myeloma
Autologous stem cell transplant remains essential component of MM therapy in eligible patients
Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone
Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE
Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm
FDA Takes New Look at Breast Implant Safety
Agency has acknowledged that breast implants may contain materials that affect people's health
Jury Finds Roundup a Major Contributor to Man’s Cancer
Landmark verdict could impact hundreds of other similar lawsuits
FDA Warns Homeopathic Company About Illegal Product Claims
Nutra Pharma warned that failure to correct the violations may result in legal action
Favorable Outcomes Seen in Long Term for ALLR3 Trial
Findings for risk-stratified tx in B-cell precursor acute lymphoblastic leukemia, late bone marrow relapse
Testosterone Replacement Slows Prostate Cancer Recurrence
Being on testosterone replacement slows time to biochemical recurrence in multivariable analysis
Model Predicts Survival in Transplant-Ineligible Myeloma Patients
U.K. Myeloma Research Alliance Risk Profile predicts overall survival based on data from two trials
FDA OKs Tecentriq for Extensive-Stage Small Cell Lung Cancer
Drug now approved as first-line treatment to be used in combination with carboplatin and etoposide
